G A Pantely, J M Porter. Show Affiliations »
Abstract
Mesh: See more » AnimalsBlood Flow Velocity/drug effectsDrug Administration RoutesEndothelial Growth Factors/administration & dosageEndothelial Growth Factors/therapeutic useFibroblast Growth Factor 2/administration & dosageFibroblast Growth Factor 2/therapeutic useHumansIschemia/drug therapyIschemia/physiopathologyLymphokines/administration & dosageLymphokines/therapeutic useNeovascularization, Physiologic/drug effectsProtein Isoforms/administration & dosageProtein Isoforms/therapeutic useVascular Endothelial Growth Factor AVascular Endothelial Growth Factors
Substances: See more » Endothelial Growth FactorsLymphokinesProtein IsoformsVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsFibroblast Growth Factor 2
Year: 2000 PMID: 11028478 DOI: 10.1016/s0735-1097(00)00885-8
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094